Document is current
Any future updates will be listed below
-
Authors
Hidding, Ute
Schaper, Miriam
Gulberti, Alessandro
Buhmann, Carsten
Gerloff, Christian
Moll, Christian K. E.
Hamel, Wolfgang
Choe, Chi-un
Pötter-Nerger, Monika
-
Clinical Trials BETA
Clinical trials referenced in this document:
drks00025329 at German Clinical Trials RegisterDocuments that mention this clinical trial
Short pulse and directional thalamic deep brain stimulation have differential effects in parkinsonian and essential tremor
https://doi.org/10.1038/s41598-022-11291-9
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB 936 C8)
Universitätsklinikum Hamburg-Eppendorf (UKE)
- License Information
-
More Information
Article History
Received: 1 May 2021
Accepted: 5 April 2022
First Online: 4 May 2022
Competing interests
: CB has received speaking fees from Abbvie, Bial, TAD Pharma, UCB Pharma and Zambon and travel expenses from Medtronic. CG received fees as a consultant or lecture fees from Bayer Vital, Boehringer Ingelheim, EBS technologies, GlaxoSmithKline, Lundbeck, Pfizer, Sanofi Aventis, Silk Road Medical and UCB. CM has received fees for teaching, lectures and consultations from Abbott, lecture fees from Inomed and fees from Brainlab for software testing. WH has received honoraria for lectures, participation in advisory boards and travel expenses from Abbott, Boston Scientific and Medtronic. MP has received honoraria for lectures, participation in advisory boards and travel expenses from Boston Scientific, Abbott, Medtronic, Licher MT and Abbvie. UH, MS, AG and CC declare no commercial or financial relationships that could be construed as a potential conflict of interest.
